|
|||||
|
|
Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells |
|
| Authors: | Brandon Cieniewicz Molly Javier Uyeda Ping |
| Institution: | 1.Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA;2.Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA;3.San Raffaele Telethon Institute for Gene Therapy, Milan, Italy;4.Center for Definitive and Curative Medicine, Stanford School of Medicine, Stanford, CA, USA |
| Abstract: | |
| Keywords: | |